Renalytix Statistics
Total Valuation
Renalytix has a market cap or net worth of 38.51 million. The enterprise value is 37.05 million.
Market Cap | 38.51M |
Enterprise Value | 37.05M |
Important Dates
The last earnings date was Friday, March 28, 2025.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +39.71% |
Shares Change (QoQ) | +62.92% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 202.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.32 |
EV / Sales | 12.40 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -1.38 |
Financial Position
The company has a current ratio of 2.43
Current Ratio | 2.43 |
Quick Ratio | 2.20 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -0.31 |
Interest Coverage | -232.81 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -128.10% |
Return on Invested Capital (ROIC) | -395.18% |
Return on Capital Employed (ROCE) | -340.56% |
Revenue Per Employee | 28,373 |
Profits Per Employee | -276,029 |
Employee Count | 102 |
Asset Turnover | 0.25 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 0.25 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 40.97 |
Average Volume (20 Days) | 59,318 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Renalytix had revenue of 2.89 million and -28.16 million in losses. Loss per share was -0.22.
Revenue | 2.89M |
Gross Profit | 568,000 |
Operating Income | -23.28M |
Pretax Income | -28.15M |
Net Income | -28.16M |
EBITDA | -23.17M |
EBIT | -23.28M |
Loss Per Share | -0.22 |
Balance Sheet
The company has 9.63 million in cash and 8.21 million in debt, giving a net cash position of 1.42 million.
Cash & Cash Equivalents | 9.63M |
Total Debt | 8.21M |
Net Cash | 1.42M |
Net Cash Per Share | n/a |
Equity (Book Value) | -1.37M |
Book Value Per Share | -0.00 |
Working Capital | 6.59M |
Cash Flow
In the last 12 months, operating cash flow was -26.86 million and capital expenditures -4,000, giving a free cash flow of -26.86 million.
Operating Cash Flow | -26.86M |
Capital Expenditures | -4,000 |
Free Cash Flow | -26.86M |
FCF Per Share | n/a |
Margins
Gross Margin | 19.63% |
Operating Margin | -804.46% |
Pretax Margin | -972.81% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Renalytix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -39.71% |
Shareholder Yield | -39.71% |
Earnings Yield | -73.11% |
FCF Yield | -69.75% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Renalytix has an Altman Z-Score of -23.03. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -23.03 |
Piotroski F-Score | n/a |